Tohru Sato, MD
Gastroenterology · San Carlos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 3 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
12 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sato’s office at (650) 321-4121 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$84,232
Medicare paid this office $84,232 for 338 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 134 | $31,346 | $234 |
| Long return visit (40+ min) | 85 | $18,163 | $161 |
| Biopsy of large bowel using a flexible endoscope | 104 | $10,628 | $102 |
| Return visit (30+ min) | 37 | $4,240 | $109 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 16 | $3,262 | $204 |
See all 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 134 | $31,346 | $234 |
| Long return visit (40+ min) | 85 | $18,163 | $161 |
| Biopsy of large bowel using a flexible endoscope | 104 | $10,628 | $102 |
| Return visit (30+ min) | 37 | $4,240 | $109 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 16 | $3,262 | $204 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 48 | $3,180 | $66 |
| New patient visit (60+ min) | 15 | $3,116 | $208 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,451 | $204 |
| New patient visit (45+ min) | 13 | $1,894 | $146 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,774 | $161 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 207 | $927 | $4 |
Procedures Medicare counted
| Colonoscopy | 163 | More than 90% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 71 | More than 70% of doctors who do this |
Who their Medicare patients are
338 Original Medicare patients in 2024. Average age 73 · Women 55% · Also on Medicaid 5% · Health risk score 0.76. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 54% · Coronary heart disease 16% · Diabetes 15% · Depression 13% · Chronic kidney disease 11% · Cancer 11% · Atrial fibrillation 10% · COPD 5% · Heart failure 4%.
The office billed $815,888, Medicare allowed $104,971 and paid $84,232; for 763 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 338 | 763 | 73 | 0.76 | $815,888 | $84,232 |
| 2023 | 313 | 714 | 73 | 0.72 | $713,375 | $77,596 |
| 2022 | 293 | 703 | 74 | 0.79 | $597,633 | $70,323 |
| 2021 | 271 | 646 | 74 | 0.74 | $573,594 | $60,880 |
| 2020 | 252 | 566 | 74 | 0.82 | $483,512 | $54,103 |
| 2019 | 261 | 587 | 73 | 0.77 | $521,895 | $57,648 |
| 2018 | 269 | 659 | 74 | 0.88 | $522,636 | $59,779 |
| 2017 | 133 | 342 | 74 | 1.03 | $240,528 | $30,053 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 104 | $24,592 | $236 |
| Biopsy of large bowel using a flexible endoscope | 114 | $13,011 | $114 |
| Long return visit (40+ min) | 61 | $12,602 | $164 |
| Return visit (30+ min) | 53 | $7,112 | $117 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 51 | $3,897 | $74 |
| New patient visit (60+ min) | 20 | $3,771 | $189 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 18 | $3,736 | $208 |
| New patient visit (45+ min) | 22 | $2,594 | $118 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 185 | $868 | $5 |
2022: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 78 | $17,769 | $228 |
| Long return visit (40+ min) | 69 | $17,470 | $168 |
| Biopsy of large bowel using a flexible endoscope | 100 | $10,681 | $107 |
| New patient visit (60+ min) | 30 | $5,614 | $187 |
| Return visit (30+ min) | 33 | $3,159 | $85 |
| New patient visit (45+ min) | 20 | $2,897 | $145 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 44 | $2,865 | $62 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 38 | $902 | $23 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 165 | $783 | $5 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 16 | $639 | $29 |
2021: 9 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 71 | $16,163 | $228 |
| Biopsy of large bowel using a flexible endoscope | 111 | $12,799 | $115 |
| Return visit (30+ min) | 58 | $9,064 | $112 |
| New patient visit (45+ min) | 28 | $4,392 | $157 |
| Long return visit (40+ min) | 24 | $3,595 | $150 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 41 | $3,244 | $75 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,747 | $97 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 167 | $833 | $5 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 34 | $710 | $20 |
2020: 10 services
| Biopsy of large bowel using a flexible endoscope | 99 | $14,013 | $142 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 36 | $8,570 | $238 |
| Return visit (30+ min) | 62 | $7,226 | $94 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 22 | $4,651 | $211 |
| New patient visit (45+ min) | 32 | $4,503 | $141 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 38 | $3,468 | $89 |
| Long return visit (40+ min) | 19 | $2,576 | $136 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $1,770 | $98 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $1,093 | $73 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 158 | $831 | $5 |
2019: 8 services
| Biopsy of large bowel using a flexible endoscope | 103 | $13,574 | $132 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 41 | $8,844 | $216 |
| New patient visit (45+ min) | 59 | $8,320 | $141 |
| Return visit (30+ min) | 48 | $5,980 | $98 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 51 | $3,824 | $72 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 15 | $3,213 | $214 |
| Long return visit (40+ min) | 21 | $2,894 | $138 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 161 | $823 | $5 |
2018: 10 services
| Biopsy of large bowel using a flexible endoscope | 106 | $13,391 | $126 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 48 | $9,032 | $188 |
| Return visit (30+ min) | 49 | $6,666 | $99 |
| New patient visit (45+ min) | 44 | $5,797 | $132 |
| Removal of large bowel tissue using a flexible endoscope | 18 | $5,475 | $304 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 39 | $3,178 | $79 |
| Long return visit (40+ min) | 22 | $3,019 | $131 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 14 | $2,950 | $211 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 168 | $838 | $5 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 54 | $658 | $11 |
2017: 8 services
| Biopsy of large bowel using a flexible endoscope | 44 | $6,056 | $138 |
| New patient visit (45+ min) | 21 | $3,090 | $147 |
| Return visit (30+ min) | 23 | $2,930 | $101 |
| Long return visit (40+ min) | 16 | $2,564 | $135 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $2,459 | $205 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 28 | $2,452 | $88 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 39 | $534 | $11 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 80 | $366 | $5 |
Drugs they prescribed that Part D paid
$621,398
Pharmacies billed $621,398 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 687) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
500 generic and 187 brand-name prescriptions · $621,398 in drug cost · 15 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Creon | 34 | $93,617 | $2,753 |
| Sod Sulf-Potass Sulf-Mag Sulf | 236 | $15,778 | $67 |
| Linzess | 13 | $14,718 | $1,132 |
| Mesalamine | 15 | $14,704 | $980 |
| Famotidine | 45 | $1,840 | $41 |
See all 8 drugs
| Creon | 34 | $93,617 | $2,753 |
| Sod Sulf-Potass Sulf-Mag Sulf | 236 | $15,778 | $67 |
| Linzess | 13 | $14,718 | $1,132 |
| Mesalamine | 15 | $14,704 | $980 |
| Famotidine | 45 | $1,840 | $41 |
| Omeprazole | 110 | $1,063 | $10 |
| Pantoprazole | 50 | $855 | $17 |
| Peg 3350-Electrolyte | 24 | $464 | $19 |
Year by year
| 2024 | 687 | 358 | 0% (0) | 27% | $621,398 |
| 2023 | 609 | 313 | 0% (0) | None | $445,793 |
| 2022 | 515 | 214 | 0% (0) | None | $485,845 |
| 2021 | 558 | 288 | 0% (0) | 50% | $218,157 |
| 2020 | 410 | 217 | 0% (0) | 52% | $372,812 |
| 2019 | 399 | 208 | 0% (0) | 44% | $59,935 |
| 2018 | 307 | 191 | 0% (0) | 36% | $42,672 |
| 2017 | 286 | 202 | 0% (0) | 30% | $49,888 |
| 2016 | 347 | 276 | None | 15% | $33,387 |
| 2015 | 66 | 56 | 0% (0) | None | $4,432 |
| 2013 | 13 | None | 0% (0) | None | $1,046 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Creon | 27 | $80,787 | $2,992 |
| Linzess | 26 | $26,891 | $1,034 |
| Mesalamine | 12 | $15,124 | $1,260 |
| Sod Sulf-Potass Sulf-Mag Sulf | 166 | $13,291 | $80 |
| Famotidine | 43 | $4,706 | $109 |
| Omeprazole | 105 | $1,580 | $15 |
| Peg 3350-Electrolyte | 35 | $867 | $25 |
| Pantoprazole | 38 | $742 | $20 |
| Lactulose | 13 | $59 | $5 |
2022: 10 drugs
| Stelara | 12 | $320,053 | $26,671 |
| Creon | 23 | $55,729 | $2,423 |
| Zenpep | 12 | $32,043 | $2,670 |
| Linzess | 35 | $27,973 | $799 |
| Mesalamine | 17 | $13,528 | $796 |
| Suprep | 85 | $9,824 | $116 |
| Famotidine | 31 | $5,265 | $170 |
| Omeprazole | 109 | $1,471 | $13 |
| Pantoprazole | 32 | $681 | $21 |
| Peg 3350-Electrolyte | 28 | $517 | $18 |
2021: 10 drugs
| Linzess | 40 | $24,760 | $619 |
| Suprep | 168 | $18,599 | $111 |
| Mesalamine | 16 | $13,005 | $813 |
| Famotidine | 37 | $5,741 | $155 |
| Budesonide Ec | 15 | $3,648 | $243 |
| Clenpiq | 12 | $2,100 | $175 |
| Omeprazole | 75 | $1,464 | $20 |
| Dicyclomine | 19 | $544 | $29 |
| Peg 3350-Electrolyte | 23 | $395 | $17 |
| Pantoprazole | 26 | $356 | $14 |
2020: 7 drugs
| Suprep | 133 | $14,003 | $105 |
| Linzess | 16 | $11,845 | $740 |
| Mesalamine | 17 | $11,403 | $671 |
| Famotidine | 33 | $6,167 | $187 |
| Omeprazole | 54 | $737 | $14 |
| Diphenoxylate-Atropine | 16 | $562 | $35 |
| Peg 3350-Electrolyte | 16 | $320 | $20 |
2019: 8 drugs
| Mesalamine | 16 | $13,861 | $866 |
| Suprep | 132 | $13,251 | $100 |
| Linzess | 11 | $6,706 | $610 |
| Famotidine | 74 | $1,378 | $19 |
| Omeprazole | 40 | $703 | $18 |
| Ranitidine | 18 | $373 | $21 |
| Gavilyte-N | 18 | $310 | $17 |
| Peg 3350-Electrolyte | 11 | $194 | $18 |
2018: 7 drugs
| Lialda | 11 | $15,602 | $1,418 |
| Suprep | 24 | $2,226 | $93 |
| Peg 3350-Electrolyte | 66 | $1,108 | $17 |
| Famotidine | 20 | $1,019 | $51 |
| Omeprazole | 29 | $888 | $31 |
| Gavilyte-N | 43 | $704 | $16 |
| Pantoprazole | 13 | $294 | $23 |
2017: 5 drugs
| Lialda | 11 | $16,450 | $1,495 |
| Gavilyte-C | 101 | $1,709 | $17 |
| Peg 3350-Electrolyte | 41 | $582 | $14 |
| Omeprazole | 20 | $403 | $20 |
| Gavilyte-N | 12 | $213 | $18 |
2016: 2 drugs
| Gavilyte-C | 222 | $3,786 | $17 |
| Metronidazole | 11 | $135 | $12 |
2015: 1 drug
| Gavilyte-C | 44 | $748 | $17 |
Money from drug and device companies
$1,138 in 2025
| 2025 | 10 | 42 | None | $1,138 |
| 2024 | 2 | 5 | None | $247 |
| 2023 | 2 | 2 | None | $269 |
| 2022 | 1 | 1 | None | $125 |
| 2019 | 2 | 2 | None | $110 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Linzess | $285 | 17 payments
|
| Madrigal Pharmaceuticals | Rezdiffra | $223 | 4 payments
|
| Lilly USA | Omvoh | $218 | 4 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $99 | 4 payments
|
| Janssen Biotech | Tremfya | $74 | 3 payments
|
| Aimmune Therapeutics | Zenpep | $63 | 2 payments
|
See all 42 published payments
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-12-21 | Xifaxan | $25 |
| Ardelyx | Meals · 2025-12-18 | Ibsrela | $28 |
| Abbvie | Meals · 2025-12-12 | Linzess | $9 |
| Abbvie | Meals · 2025-12-05 | Linzess | $27 |
| Novo Nordisk | Meals · 2025-11-20 | Wegovy | $20 |
| Abbvie | Meals · 2025-11-19 | Linzess | $7 |
| Abbvie | Meals · 2025-11-12 | Linzess | $12 |
| Phathom Pharmaceuticals | Meals · 2025-11-05 | Voquezna | $22 |
| Celltrion USA | Meals · 2025-10-30 | Vegzelma | $21 |
| Abbvie | Meals · 2025-10-29 | Linzess | $18 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-10-24 | Xifaxan | $25 |
| Ardelyx | Meals · 2025-10-23 | Ibsrela | $28 |
| Aimmune Therapeutics | Meals · 2025-10-06 | Zenpep | $37 |
| Madrigal Pharmaceuticals | Meals · 2025-09-24 | Rezdiffra | $35 |
| Abbvie | Meals · 2025-09-19 | None | $27 |
| Janssen Biotech | Meals · 2025-09-11 | Tremfya | $26 |
| Abbvie | Meals · 2025-09-09 | Creon | $7 |
| Abbvie | Meals · 2025-09-05 | Linzess | $15 |
| Abbvie | Meals · 2025-08-22 | Linzess | $16 |
| Lilly USA | Meals · 2025-08-18 | Omvoh | $26 |
| Aimmune Therapeutics | Meals · 2025-08-15 | Vowst | $26 |
| Janssen Biotech | Meals · 2025-08-13 | Tremfya | $24 |
| Abbvie | Meals · 2025-08-07 | Viberzi | $29 |
| Abbvie | Meals · 2025-07-25 | Viberzi | $14 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-07-08 | Xifaxan | $25 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-06-23 | Xifaxan | $25 |
| Madrigal Pharmaceuticals | Meals · 2025-06-10 | Rezdiffra | $28 |
| Abbvie | Meals · 2025-06-07 | Creon | $8 |
| Abbvie | Meals · 2025-05-27 | Linzess | $15 |
| Lilly USA | Meals · 2025-05-01 | Omvoh | $125 |
| Janssen Biotech | Meals · 2025-04-29 | Tremfya | $24 |
| Abbvie | Meals · 2025-04-16 | Creon | $14 |
| Lilly USA | Meals · 2025-04-07 | Omvoh | $34 |
| Abbvie | Meals · 2025-03-25 | Creon | $23 |
| Abbvie | Meals · 2025-03-21 | Creon | $14 |
| Madrigal Pharmaceuticals | Meals · 2025-03-17 | Rezdiffra | $32 |
| Celltrion USA | Meals · 2025-03-10 | Vegzelma | $33 |
| Phathom Pharmaceuticals | Meals · 2025-03-04 | Voquezna | $22 |
| Phathom Pharmaceuticals | Meals · 2025-03-04 | Voquezna | $2 |
| Lilly USA | Meals · 2025-02-25 | Omvoh | $33 |
| Abbvie | Meals · 2025-01-22 | Linzess | $30 |
| Madrigal Pharmaceuticals | Meals · 2025-01-21 | Rezdiffra | $127 |
See earlier years (2024, 2023, 2022, 2019)
2024: $247
| Lilly USA | Omvoh | $189 | 3 payments
|
| Abbvie | Creon | $58 | 2 payments
|
2023: $269
| E.R. Squibb & Sons L.L.C. | Zeposia | $150 | 1 payment
|
| AbbVie | Rinvoq | $119 | 1 payment
|
2022: $125
| Abbvie | Skyrizi | $125 | 1 payment
|
2019: $110
| AbbVie | None | $91 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $19 | 1 payment
|
Professional record
- NPI
- 1497847248
- Licence
- CA A066832
- Trained
- State University of New York at Stony Brook, School of Medicine, 1995
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-09-29
- NPI last updated
- 2020-06-08
- NPI record certified
- 2020-06-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3801 Miranda Ave, Palo Alto, CA, 94304